The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 million Americans on Medicare or Medicaid.

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are used to treat obesity